Literature DB >> 2545818

Glycine binding to rat cortex and spinal cord: binding characteristics and pharmacology reveal distinct populations of sites.

W F White1, K L Brown, D M Frank.   

Abstract

Glycine is the principal inhibitory neurotransmitter in posterior regions of the brain. In addition, glycine serves as an allosteric regulator of excitatory neurotransmission mediated by the N-methyl-D-aspartate (NMDA) acidic amino acid receptor subtype. The studies presented here characterize [3H]glycine binding to washed membranes prepared from rat spinal cord and cortex, areas enriched in glycine inhibitory and NMDA receptors, respectively, in an attempt to define the glycine recognition sites on the two classes of receptors. Specific binding for [3H]glycine was seen in both cortex and spinal cord. Saturation analyses in cortex were best fitted by a two-site model with respective equilibrium dissociation constants (KD values) of 0.24 and 5.6 microM and respective maximal binding constants (Bmax values) of 3.4 and 26.7 pmol/mg of protein. Similar analyses in spinal cord were best fitted by a one-site model with a KD of 5.8 microM and Bmax of 20.2 pmol/mg of protein. Na+ had no effect on [3H]glycine binding to cortical membranes but increased the binding to spinal cord membranes by greater than 15-fold. This Na+-dependent binding may reflect glycine binding to the recognition site of the high-affinity, Na+-dependent glycine uptake system. Several short-chain, neutral amino acids displaced [3H]glycine binding from both cortical and spinal cord membranes. The most potent displacers of [3H]glycine binding to cortical membranes were D-serine and D-alanine, followed by the L-isomers of serine and alanine and beta-alanine. In contrast, D-serine and D-alanine were similar in potency to L-serine in spinal cord membranes. Compounds active at receptors for the acidic amino acids had disparate effects on the binding of [3H]glycine. At 10 microM, NMDA resulted in a 25% increase, whereas D- and L-2-amino-5-phosphonovaleric acid at 100 microM resulted in a 30% decrease, in [3H]glycine binding to cortical membranes. Kynurenic acid was the most potent of the acidic amino acid-related compounds at displacing [3H]glycine binding. In cortical membranes, kynurenic acid displacement was resolved into a high- and a low-affinity component; the high-affinity component displaced the high-affinity component of [3H]glycine binding.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545818     DOI: 10.1111/j.1471-4159.1989.tb07362.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Evidence for heterogenous glycine domains but conserved multiple states of the excitatory amino acid recognition site of the NMDA receptor: regional binding studies with [3H]glycine and [3H]L-glutamate.

Authors:  R D O'Shea; D T Manallack; E L Conway; L D Mercer; P M Beart
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Glycine and D-serine decrease MK-801-induced hyperactivity in mice.

Authors:  M Nilsson; A Carlsson; M L Carlsson
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices.

Authors:  Hao Huang; Latifa Barakat; Doris Wang; Angélique Bordey
Journal:  J Physiol       Date:  2004-08-26       Impact factor: 5.182

4.  Modulation by glycine on vascular effect of NMDA: in vivo experimental researches.

Authors:  L Berrino; S Vitagliano; S Maione; F Rossi
Journal:  Amino Acids       Date:  1993-02       Impact factor: 3.520

5.  Modulation by glycine on vascular effects of NMDA:in vivo experimental research.

Authors:  L Berrino; S Vitagliano; S Maione; E Lampa; F Rossi
Journal:  Amino Acids       Date:  1993-06       Impact factor: 3.520

6.  Two types of steady-state desensitization of N-methyl-D-aspartate receptor in isolated hippocampal neurones of rat.

Authors:  I V Chizhmakov; N I Kiskin; O A Krishtal
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.